- Home
- CSIQ vs ATXS Comparison
CSIQ vs ATXS Comparison
Compare CSIQ & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSIQ | ATXS |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 746.1M | 676.1M |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CSIQ | ATXS |
|---|---|---|
| Price | $27.06 | $12.65 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $17.63 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 8.3M | 1.0M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,899,139,000.00 | $706,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24.59 | N/A |
| P/E Ratio | $112.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.57 | $3.56 |
| 52 Week High | $34.59 | $12.72 |
Technical Indicators
Market Signals| Indicator | CSIQ | ATXS |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 67.26 |
| Support Level | $20.27 | $12.29 |
| Resistance Level | $34.59 | $12.57 |
| Average True Range (ATR) | 3.53 | 0.20 |
| MACD | -0.57 | -0.13 |
| Stochastic Oscillator | 49.20 | 92.50 |
Price Performance
Historical ComparisonAbout CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.